COVID-19 Treatment at a Glance

Area of Science:

• Infectious Diseases
• Virology
• Critical Care Medicine

Background:

• The rapid global spread of coronavirus disease 2019 (COVID-19) necessitates urgent development of effective treatments.
• Currently, no definitive treatment with robust study results exists for COVID-19.
• Understanding the pathophysiology of COVID-19 is incomplete, complicating treatment development.

Purpose of the Study:

• To review the current landscape of COVID-19 treatments.
• To evaluate the efficacy, reliability, and safety of proposed and existing therapeutic options.
• To highlight the role of supportive therapies in managing severe COVID-19 cases.

Main Methods:

• Review of existing clinical trial data and scientific literature on COVID-19 treatments.
• Analysis of proposed therapeutic agents, including antivirals, chloroquine/hydroxychloroquine, tocilizumab, convalescent plasma, and steroids.
• Assessment of the role of supportive care in intensive care unit settings.

Main Results:

• The efficacy and safety of many COVID-19 treatment alternatives remain under debate.
• Antiviral drugs and chloroquine/hydroxychloroquine are primary therapeutic strategies.
• Supportive therapies are the cornerstone of treatment for patients in intensive care units.

Conclusions:

• There is an urgent need for evidence-based treatments for COVID-19.
• The current therapeutic options for COVID-19 require further rigorous investigation.
• Supportive care remains essential for managing critically ill COVID-19 patients while definitive treatments are sought.